DelveInsigth’s Zollinger-Ellison Syndrome market report provides an in-depth understanding of the Zollinger-Ellison Syndrome, historical and forecasted epidemiology, as well as Zollinger-Ellison Syndrome market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan).
Some of the Key Highlights from the Zollinger-Ellison Syndrome Market Report
- According to NIDDK, Zollinger-Ellison Syndrome is extremely rare. It affects one in a million people globally. It is more common in men than in women and usually occurs between the ages of 30 and 50.
- In the United States, approximately 0.1-1 percent of all patients with duodenal ulcers have Zollinger-Ellison Syndrome (ZES).
- Key players such as Phathom Pharmaceuticals and others are diligently working toward the development of novel therapies for Zollinger-Ellison Treatment.
- Vonoprazan (Phathom Pharmaceuticals), is a late-stage investigational potassium competitive acid blocker (P-CAB) for the treatment of gastric acid-related disorders.
For a better understanding of the disease, request sample @ Zollinger-Ellison Syndrome Symptoms, Diagnosis and Therapy
The Zollinger-Ellison Syndrome market report covers current treatment practices, emerging drugs, Zollinger-Ellison Syndrome market share of individual therapies, as well as current and forecasted Zollinger-Ellison Syndrome market Size from 2018 to 2030, segmented by seven major markets.
Zollinger-Ellison Syndrome: Overview
The Zollinger-Ellison Syndrome (ZES) is characterized by the development of a tumor (gastrinoma) or tumors that secrete excessive amounts of gastrin, a hormone that stimulates the stomach’s acid production. Many people who are affected develop multiple gastrinomas, which are thought to be cancerous (malignant). The majority of patients’ tumors develop in the pancreas and/or the upper region of the small intestine (duodenum). Individuals with ZES may develop peptic ulcers of the stomach, duodenum, and/or other regions of the digestive tract as a result of excessive acid production (gastric acid hypersecretion).
Zollinger-Ellison Syndrome Epidemiology Segmentation
The Zollinger-Ellison Syndrome report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
- Zollinger-Ellison Syndrome Incident Cases
- Zollinger-Ellison Syndrome Gender-Specific Cases
- Zollinger-Ellison Syndrome Age-Specific Cases
- Zollinger-Ellison Syndrome Diagnosed and Treated Cases
Get the complete epidemiology analysis @ Zollinger-Ellison Syndrome Risk Factors
Zollinger-Ellison Syndrome Treatment Landscape
The Zollinger-Ellison syndrome (ZES) treatment goals are medical control of gastric acid hypersecretion and surgical resection of the tumor. Proton Pump Inhibitors (PPIs) drugs that are used to reduce stomach acid production and allow ulcers to heal include lansoprazole (Prevacid), omeprazole (Prilosec, Zegerid), pantoprazole (Protonix), dexlansoprazole (Dexilant), esomeprazole (Nexium), and rabeprazole (Aciphex). For patients with advanced cancer, a combination of therapies such as surgery, chemotherapy, Octreotide (Sandostatin), targeted drug therapy, or radiation may be beneficial.
Zollinger-Ellison Syndrome Market
Extensive research and development activities by pharmaceutical companies such as Phathom Pharmaceuticals, as well as the anticipated launch of approved therapies such as Vonoprazan and others will drive Zollinger-Ellison Syndrome market growth during the forecast period, i.e., 2021–2030.
Zollinger-Ellison Syndrome Pipeline Therapies and Key Companies
- Vonoprazan: Phathom Pharmaceuticals
For further information on the emerging drugs, visit Zollinger-Ellison Syndrome Treatment Drugs
Table of Contents
| 1. | Key Insights |
| 2. | Zollinger-Ellison Syndrome (ZES) Market Overview at a Glance |
| 3. | Executive summary |
| 4. | Organizations |
| 5. | Disease Overview: Zollinger-Ellison Syndrome (ZES) |
| 6. | Zollinger-Ellison Syndrome Epidemiology and Patient Population |
| 7. | Zollinger-Ellison Syndrome Current Treatment Practices |
| 8. | Zollinger-Ellison Syndrome Unmet Needs |
| 9. | Zollinger-Ellison Syndrome Marketed Drugs |
| 10. | Zollinger-Ellison Syndrome Emerging Therapies |
| 11. | Zollinger-Ellison Syndrome (ZES): 7MM Analysis |
| 12. | Zollinger-Ellison Syndrome Market Drivers |
| 13. | Zollinger-Ellison Syndrome Market Barriers |
| 14. | Zollinger-Ellison Syndrome Market Access and Reimbursement |
| 15. | SWOT Analysis |
| 16. | Case studies |
| 17. | KOL Views |
| 18. | Appendix |
| 19. | DelveInsight Capabilities |
| 20. | Disclaimer |
| 21. | About DelveInsight |
| 22. | Disclaimer |
Know more about report offerings @ Zollinger-Ellison Syndrome Market Size
Related Reports
Get comprehensive historical and forecast analysis of Alagille Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Mirum Pharmaceuticals, Albireo, among others.
Get comprehensive historical and forecast analysis of Fragile X Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Neuren Pharmaceuticals, Ovid Therapeutics, Tetra Therapeutics, Confluence Pharmaceuticals, Zynerba Pharmaceuticals, among others.
DelveInsight’s “Metastatic Bone Pain – Market Insights, Epidemiology, and Market Forecast-2030” report.
DelveInsight’s “Metastatic Melanoma – Market Insights, Epidemiology, and Market Forecast-2030” report.
DelveInsight’s “Alport Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Get comprehensive historical and forecast analysis of Acute Myeloid Leukemia Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Pfizer, Abbvie, Astellas Pharma, among others.
Get comprehensive historical and forecast analysis of Multiple Myeloma Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Johnson & Johnson, Amgen, BioLineRx, Bristol-Myers Squibb, ExCellThera, Pfizer, Takeda, Precision BioSciences, Poseida Therapeutics, among others.
DelveInsight’s “Friedreich’s Ataxia – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Friedreich’s Ataxia, historical and forecasted epidemiology as well as the Friedreich’s Ataxia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Metastatic Colorectal Cancer Market
Get comprehensive historical and forecast analysis of Metastatic Colorectal Cancer Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Merck, Eli Lilly, Bristol-Myers Squibb, Amgen, Taiho Oncology, Pfizer, Isofol Medical, Ab Science, Effector Therapeutics, Vaximm, Cardiff Oncology, others.
Get comprehensive historical and forecast analysis of Dravet Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Biocodex, GW Pharmaceuticals, Zogenix, Ovid Therapeutics, PTC Therapeutics, among others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Us
Sandeep Joshi
info@delveinsight.com
+1(919)321-6187
Connect With Us at:
Contact Information:
Sandeep Joshi info@delveinsight.com +1(919)321-6187
Tags:
Menafn, IPS, Reportedtimes, PR-Wirein, Extended Distribution, iCN Internal Distribution, Research Newswire, English
Contact Information:
Sandeep Joshi
info@delveinsight.com
+1(919)321-6187
